Together we will beat cancer

Donate

Opinion: ‘The UK must be more ambitious than just clearing the cancer backlog’

Cancer Research UK estimates that 3 million fewer people were screened for cancer between March and September last year, meaning around 9,200 fewer patients started cancer treatment as a result in England alone – a 42% drop.

Read More

COVID-19 vaccine and cancer – latest updates

Recently, news of a COVID-19 vaccine has dominated headlines. We’ve summarised all the information that is out there, with rolling updates, in our new vaccine blog post.

Read More

One year on: How has COVID-19 affected cancer services?

Disruption to cancer screening, diagnosis and treatment has led to more than 45,000 fewer people starting cancer treatment between March 2020 and March 2021.

Read More

Opinion: ‘We’re speaking with One Cancer Voice, but is anyone listening?’

We joined 46 other cancer charities to outline what we need from UK Governments and the NHS coming out of the pandemic to move towards world-leading services.

Read More

Coronavirus reports – Part 9: “I am very relieved but I am not naïve”

We caught up with people living with cancer across the country, to find out how the coronavirus pandemic has been affecting them and their families.

Read More

How repurposing a drug in a COVID-19 trial could benefit people with cancer

We spoke with Professor Kev Dhaliwal, chief investigator of the SPIKE-1 trial, about how repurposing a drug in a COVID-19 trial could benefit people with cancer.

Read More

Cancer services during COVID-19: 40,000 fewer people starting treatment

There’s been a steady stream of figures since the pandemic began, each laying bare what many people have seen first-hand – the impact on health services.

Read More

COVID-19 in people with cancer – what we know so far

More than 8 months since the pandemic began, we now have a clearer picture of how COVID-19 affects people with cancer.

Read More

Opinion: “There’s cause for optimism in 2021 and beyond”

COVID-19 changed so much of our plans, but it didn’t change everything. In this dark year, there were still pockets of light, writes our CEO Michelle Mitchell.

Read More

Cancer research in 2020: A spotlight on Manchester

2020 has certainly been tough, and no industry has been left untouched by the effects of the pandemic. And while the same undoubtedly goes for our work, we’ve once again been inspired by the resilience and determination of our researchers.

Read More